Stockscreener 앱 받기
7.65
2.41%
0.18
시간 외 거래:
7.65
전일 마감가:
$7.47
열려 있는:
$7.46
하루 거래량:
140.45K
Relative Volume:
0.96
시가총액:
$261.27M
수익:
$38.79M
순이익/손실:
$-6.57M
주가수익비율:
-32.14
EPS:
-0.238
순현금흐름:
$-8.52M
1주 성능:
+0.26%
1개월 성능:
-12.87%
6개월 성능:
-11.76%
1년 성능:
+14.69%
1일 변동 폭
$7.34
$7.735
1주일 범위
$7.34
$8.11
52주 변동 폭
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.65 | 255.13M | 38.79M | -6.57M | -8.52M | -0.238 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-12 | 개시 | B. Riley Securities | Buy |
| 2026-01-09 | 개시 | Piper Sandler | Overweight |
| 2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2022-08-08 | 재개 | Craig Hallum | Buy |
| 2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 개시 | Goldman | Buy |
모두보기
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec Pharmaceuticals (TSX:FRX) Shares Drift Below Key Average Level - Kalkine Media
Fennec Pharma (TSX:FRX) Falls Below Key Average in TSX Index - Kalkine Media
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below 50 Day Moving AverageTime to Sell? - MarketBeat
Retail Surge: Is Fennec Pharmaceuticals Inc still a buy after recent gains2026 Big Picture & Reliable Trade Execution Plans - baoquankhu1.vn
Breakout Zone: Can Fennec Pharmaceuticals Inc stock outperform in a bear marketTrend Reversal & Long-Term Capital Growth Ideas - baoquankhu1.vn
Fennec to Report 2025 Results as Global Rollout of PEDMARK Advances - TipRanks
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 - The Manila Times
Fennec Pharmaceuticals Inc. - Mena FN
Cipla To Hold Off On Pediatric Cancer Drug Generic Until 2033 - Law360
B Riley Reaffirms Fennec's Buy Rating, US$16.00 Price Target After Cipla Settlement - marketscreener.com
FENC Stock Quote - RichTv
Fennec Pharmaceuticals (FENC) delays Cipla generic PEDMARK rival until 2033 - Stock Titan
Fennec Pharmaceuticals announces settlement agreement resolving Pedmark patent litigation - marketscreener.com
Fennec settles patent case with Cipla over generic PEDMARK - Investing.com
Fennec Pharmaceuticals Announces Settlement Agreement Resolving Pedmark Patent Litigation - TradingView
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation - The Manila Times
Patent deal delays PEDMARK generic, drug for chemo hearing loss, to 2033 - Stock Titan
(FRX) Technical Patterns and Signals (FRX:CA) - Stock Traders Daily
Adherex Technologies (NASDAQ:FENC) Cut to Buy at Wall Street Zen - MarketBeat
Liquidity Mapping Around (FENC) Price Events - Stock Traders Daily
(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Hits Day Low of CAD 10.35 Amid Price Pressure - Markets Mojo
Adolescent cancer patients face unique survivorship hurdles, Fennec Pharmaceuticals asserts - Traders Union
Fennec Pharmaceuticals Announces Clinical Research Collaboration With Tampa General Hospital Cancer Institute - Florida Hospital News and Healthcare Report
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will Fennec Pharmaceuticals Inc. stock maintain growth story2025 Sector Review & Fast Exit and Entry Strategy Plans - Naître et grandir
Can Fennec Pharmaceuticals Inc sustain earnings growth2025 Bull vs Bear & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Fennec Pharmaceuticals (TSX:FRX) Moves Higher on Renewed Trading Focus - Kalkine Media
Aug Chart Watch: Does Fennec Pharmaceuticals Inc outperform in volatile marketsJuly 2025 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Above 50-Day Moving AverageWhat's Next? - MarketBeat
Fennec Pharmaceuticals Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline - Finviz
Fennec, Tampa General launch real-world PEDMARK oncology study - TipRanks
Fennec (FENC) backs PEDMARK real-world study at Tampa General - Stock Titan
Dow Update: Why is Fennec Pharmaceuticals Inc stock going downJuly 2025 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
Stocks in play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Pharmaceuticals Collaborates With TGH Cancer Institute for Pedmark Study - marketscreener.com
Fennec Pharmaceuticals Inc. and Tampa General Hospital Cancer Institute Initiate Clinical Research Collaboration - marketscreener.com
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewswire
Fennec (NASDAQ: FENC) CFO acquires 1,191 common shares via award vesting - Stock Titan
Fennec Pharmaceuticals (FENC) director trades options and common shares - Stock Titan
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
FENC (NASDAQ: FENC) insider files to sell 10,079 shares via option exercise - Stock Titan
Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Finviz
FENC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Adherex Technologies (FENC) to Release Quarterly Earnings on Monday - MarketBeat
FENC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
FENC Should I Buy - Intellectia AI
FENC SEC FilingsFennec Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Public market insider buying at Fennec Pharmaceuticals (FRX) - The Globe and Mail
(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Raykov Rosty | Director |
Mar 02 '26 |
Sale |
8.36 |
10,079 |
84,260 |
103,996 |
1.20%
0.06%
자본화:
|
볼륨(24시간):